ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp. (Nasdaq: ARYA) was a healthcare-focused blank-check company sponsored by Perceptive Advisors, the New York-based life sciences investment firm. The SPAC completed its initial public offering in January 2019 on Nasdaq, targeting acquisition opportunities within the biopharmaceutical and life sciences sectors. In July 2020, the company filed a Form 15-12B with the SEC, formally terminating its registration under Section 12(b) of the Securities Exchange Act following the close of its business combination — marking the conclusion of the SPAC's lifecycle as a standalone public vehicle. For complete filing history, deal terms, and sponsor data on ARYA and thousands of other SPACs, sign up for full access at SpacDesk.